We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AVXL icon
101
Anavex Life Sciences
AVXL
$66.7M
$66.7M $0.7194 2.78%
CRDF icon
102
Cardiff Oncology
CRDF
$65.3M
$65.3M $0.8390 0.87%
TENX icon
103
Tenax Therapeutics
TENX
$65.1M
$65.1M $1.43 0.7%
VTVT icon
104
vTv Therapeutics
VTVT
$65.1M
$65.1M $16.23 6.13%
CHRS icon
105
Coherus Oncology
CHRS
$63.3M
$63.3M $0.4099 14.3%
FBIO icon
106
Fortress Biotech
FBIO
$63.3M
$63.3M $1.89 3.85%
CSBR icon
107
Champions Oncology
CSBR
$61.8M
$61.8M $4.44 3.27%
ONCY icon
108
Oncolytics Biotech
ONCY
$59.9M
$59.9M $0.4403 15.1%
IBIO icon
109
iBio
IBIO
$59.8M
$59.8M $0.8481 13.4%
NTRB icon
110
Nutriband
NTRB
$58.6M
$58.6M $4.82 13.8%
OKYO icon
111
OKYO Pharma
OKYO
$57.7M
$57.7M $1.10 0.9%
MIST icon
112
Milestone Pharmaceuticals
MIST
$57.3M
$57.3M $0.4604 11.4%
CGTX icon
113
Cognition Therapeutics
CGTX
$57.1M
$57.1M $0.6000 4.75%
CRBP icon
114
Corbus Pharmaceuticals
CRBP
$56.7M
$56.7M $2.75 8.64%
BOLD icon
115
Boundless Bio
BOLD
$56.7M
$56.7M $2.40 0.41%
TNXP icon
116
Tonix Pharmaceuticals
TNXP
$54.8M
$54.8M $2.82 4.08%
RNXT icon
117
RenovoRx
RNXT
$54M
$54M $1.12 7.69%
XLO icon
118
Xilio Therapeutics
XLO
$53.9M
$53.9M $7.63 1.19%
XBIT icon
119
XBiotech
XBIT
$52.7M
$52.7M $1.73 2.81%
HRTX icon
120
Heron Therapeutics
HRTX
$51.9M
$51.9M $0.2730 3.26%
SPRO icon
121
Spero Therapeutics
SPRO
$50.9M
$50.9M $0.8740 3.03%
HOWL icon
122
Werewolf Therapeutics
HOWL
$50.1M
$50.1M $1.03 1.9%
GANX icon
123
Gain Therapeutics
GANX
$49.4M
$49.4M $1.11 5.93%
VRCA icon
124
Verrica Pharmaceuticals
VRCA
$49M
$49M $2.85 9.24%
APLM icon
125
Apollomics
APLM
$48M
$48M $16.45 2.32%

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 294 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $17.7B.

The largest by market cap are Clinuvel Pharmaceuticals (CUVL) at $245M, Lexeo Therapeutics (LXEO) at $242M and Allogene Therapeutics (ALLO) at $241M.

Among institutional investors, Faeth Therapeutics (FTH) drew the most net new fund positions in Q3 2026: 41 funds opened new positions, taking total fund holders up 34 (76%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.